TY - JOUR T1 - Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial JO - The Lancet Diabetes & Endocrinology UR - https://eprints.whiterose.ac.uk/id/eprint/205102 PY - 2023/10/18 AU - Abani O AU - Abbas A AU - Abbas F AU - Abbas J AU - Abbas K AU - Abbas M AU - Abbasi S AU - Abbass H AU - Abbott A AU - Abdallah N AU - Abdelaziz A et al ED - DO - DOI: 10.1016/s2213-8587(23)00253-x PB - Elsevier BV VL - 11 IS - 12 SP - 905 EP - 914 Y2 - 2025/05/22 ER -